Judge Orders 2 More Bellwethers In Fosamax MDL

Law360, New York (February 8, 2011, 2:48 PM EST) -- Merck & Co. will help select two additional bellwether cases for trial in a multidistrict litigation over its osteoporosis drug Fosamax following a federal judge's ruling that a couple of key issues still needed to be hashed out in court.

Judge John F. Keenan on Monday told the plaintiffs steering committee and Merck to confer on which two cases should go up for trial, according to his order in the U.S. District Court for the Southern District of New York.

Before he considers remanding the remaining...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.